XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Other Non-current Assets
6 Months Ended
Jun. 30, 2023
Other Assets, Noncurrent Disclosure [Abstract]  
Other Non-current Assets
7.
Other Non-current Assets

Other non-current assets consisted of the following (in thousands):

 

 

June 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred offering costs

 

$

2,222

 

 

$

2,133

 

Restricted cash

 

 

—

 

 

 

1,327

 

Deferred tax asset

 

 

542

 

 

 

533

 

 

$

2,764

 

 

$

3,993

 

Restricted cash consisted of collateral deposits for the office space leased by the Company's former wholly owned subsidiary, Freeline Therapeutics GmbH. This collateral was released upon the sale of Freeline Therapeutics GmbH in the six months ended June 30, 2023.